Your browser doesn't support javascript.
loading
The Landscape of Lyme Borreliosis Surveillance in Europe.
Nagarajan, Archana; Skufca, Jozica; Vyse, Andrew; Pilz, Andreas; Begier, Elizabeth; Riera-Montes, Margarita; Gessner, Bradford D; Stark, James H.
Afiliação
  • Nagarajan A; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
  • Skufca J; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
  • Vyse A; Vaccines Medical Affairs, Pfizer UK Ltd, Tadworth, United Kingdom.
  • Pilz A; Pfizer Global Medical Affairs, Vaccines, Vienna, Austria.
  • Begier E; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Riera-Montes M; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
  • Gessner BD; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
  • Stark JH; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
Vector Borne Zoonotic Dis ; 23(4): 142-155, 2023 04.
Article em En | MEDLINE | ID: mdl-37071402
ABSTRACT

Purpose:

Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe and the incidence of LB is increasing owing to an expansion in tick habitats. However, LB surveillance is quite heterogeneous across the continent, and for those countries with publicly available data, it is difficult to understand the differences in incidence between countries. The objective of our study was to summarize the publicly available data from surveillance for LB in the form of surveillance reports and/or dashboards and to compare the information available for various countries.

Methods:

We identified publicly available LB data (online dashboards and surveillance reports) in the European Union, European Economic Area, the United Kingdom, Russia, and Switzerland.

Results:

Of the 36 countries studied, 28 had LB surveillance in place; 23 had surveillance reports, and 10 had dashboards. The dashboards, in general, had more granular data compared with the surveillance reports, but the reports covered longer time periods. LB annual cases, incidence, age, and sex-stratified LB data; manifestations; and regional data were available for most of the countries. LB case definitions varied significantly among the countries.

Conclusion:

The study highlights large differences in LB surveillance systems, including representativeness, case definitions, type of data available that might inhibit comparison of data between countries and accurate determination of burden of disease, and risk groups within countries. Standardization of case definitions across countries would be a useful first step enabling comparisons between countries and contribute to recognizing the true burden of LB in Europe.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Lyme / Doenças Transmitidas por Carrapatos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Lyme / Doenças Transmitidas por Carrapatos Idioma: En Ano de publicação: 2023 Tipo de documento: Article